Quantcast

Latest Cepheid Stories

2014-10-01 20:23:39

Cepheid Acquires Customer Relationships from Distribution Partner LABSCO LOUISVILLE, Ky., Oct. 1, 2014 /PRNewswire/ -- LABSCO, the leading specialty sales agent of innovative laboratory technologies and products to hospitals, physician office laboratories and alternate healthcare settings announces that, effective October 1, 2014, it has entered into a purchase agreement with Cepheid, a manufacturer partner for existing customer relationships. LABSCO has partnered with Cepheid since...

2014-10-01 16:27:26

Acquires Customer Relationships from Former Distribution Partner SUNNYVALE, Calif., Oct. 1, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that, effective today, it has entered into a purchase agreement to acquire the customer relationships from its former distribution partner, the Laboratory Supply Company (LABSCO). LABSCO has partnered with Cepheid since early 2012 to drive adoption of the GeneXpert® System in US hospitals with fewer than 150 beds, which increased...

2014-10-01 16:27:24

SUNNYVALE, Calif., Oct. 1, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 third quarter ended September 30, 2014 on Thursday, October 16, 2014, after the close of the market. The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, October 16, 2014, to discuss the results. To access the live webcast, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the...

2014-09-04 08:26:04

SUNNYVALE, Calif., Sept. 4, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that it has been named to Forbes magazine's list of the World's Most Innovative Growth Companies, reflecting companies identified by investors as innovation leaders. "Cepheid's GeneXpert(®) Systems and associated tests are continuing to lead innovation in the field of molecular diagnostics, bringing the power of accurate, rapid and easy-to-use diagnostic tests to virtually any location around the world,"...

2014-09-03 08:32:56

First molecular test indicated for samples from both males and females SUNNYVALE, Calif., Sept. 3, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) TV, an on-demand molecular test for rapid, accurate and reproducible identification of Trichomoniasis (TV) infections in both males and females. The test will be marketed as a CE-IVD product under the European Directive on In Vitro Diagnostic Medical Devices, bringing the total number of CE-IVD tests available...

2014-09-02 08:28:48

Redundant targets extend coverage to provide detection of seasonal and emerging novel viruses SUNNYVALE, Calif., Sept. 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) announced today the release of Xpert(® )Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection. The test will be marketed as a CE-IVD product under the European Directive on In Vitro Diagnostic Medical Devices, bringing the total number of...

2014-07-31 16:29:02

SUNNYVALE, Calif., July 31, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. Wedbush Life Sciences Management Access Conference, New York, NYWednesday, August 13, 2014 at 9.10 a.m. Eastern Time Baird Health Care Conference, New York, NYThursday, September 4, 2014 at 8.30 a.m. Eastern Time Accessing Live Webcasts To access the live webcasts for these...

2014-07-30 16:29:31

No Customer or Revenue Impact Expected SUNNYVALE, Calif., July 30, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing through the Premier GPO will be able to continue their relationship with Cepheid through other GPOs including Amerinet, Baycare, HPA, MedAssets, Novation, and ROi, in addition to the recently announced agreement with HealthTrust, or directly with...

2014-07-29 08:31:43

Program to Enable Broader Access to Groundbreaking Tuberculosis Diagnostic SUNNYVALE, Calif., July 29, 2014 /PRNewswire/ -- With the recent completion of a record shipment of 774 GeneXpert systems to a single country in one quarter, Cepheid (Nasdaq: CPHD) today applauded groundbreaking tuberculosis programs in China where more than a million new cases of tuberculosis (TB) are reported each year. Combined with systems placed previously, the second quarter placements bring the...

2014-07-17 16:26:27

Record HBDC Placements and Strength in North America Reagents Drive 27% Clinical Growth SUNNYVALE, Calif., July 17, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today reported revenues for the second quarter of 2014 of $116.5 million, representing growth of 21% from $96.0 million for the second quarter of 2013. Net loss in the second quarter of 2014 was $(9.8) million, or $(0.14) per share, which compares to net loss of $(6.6) million, or $(0.10) per share, in the second quarter of 2013....


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.